Navigating Preclinical Drug Development Challenges with Lipid-Based Formulations
Summary: In this webinar, experts will discuss the barriers to developing LBFs and share strategies for translating them into clinically and commercially viable drug products. The speakers will also examine lipid excipients from the perspective of dosing in preclinical models for toxicology studies and their safety profile. Additionally, the experts will explore preformulation techniques and modeling tools to gain insights into LBF-mediated oral bioavailability. Finally, case studies will be presented on transitioning LBFs from preclinical toxicology to a viable formulation suitable for an accelerated pathway in the clinic.